Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the officials of Navin Fluorine International Limited ....
NAVINFLUOR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Navin Fluorine informed exchanges about an analyst/institutional investor meeting scheduled for May 22, 2026. The enclosed investor presentation (April 2026) reveals exceptional FY26 results. Q4FY26 revenue was Rs. 937.7 Crs (+34% YoY) with operating EBITDA of Rs. 321.2 Crs (+80% YoY) at a margin of 34.2%. Full-year FY26 revenue reached Rs. 3,313.9 Crs (+41% YoY), operating EBITDA was Rs. 1,081.7 Crs (+103% YoY) at 32.6% margin, and operating PBT was Rs. 814.6 Crs (+142% YoY). Q4 segmental revenue included HPP at Rs. 326 Crs (+20%), Specialty Chemicals at Rs. 360 Crs (+39%), and CDMO at Rs. 186 Crs (+61%). Three capex programs are underway: additional HFC capacity (~Rs. 600–825 Crs revenue potential, commissioned Q3FY27), MPP de-bottlenecking at Dahej (~Rs. 140–160 Crs, Q3FY27), and Advanced Materials (Q1FY27). The FY26 EPS stands at Rs. 130.5 vs Rs. 58.1 in FY25.
The filing confirms extremely strong financial growth across all segments and signals positive momentum ahead of the investor meet, likely supporting a bullish outlook for the stock given the doubling of operating profitability and robust capex pipeline.